Compare Seagate Technology Holdings PLC (STX) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Seagate Technology Holdings PLC vs GeneDx Holdings Corp — how do they compare? Seagate Technology Holdings PLC trades at $877.77 (market cap $201.45B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.58B). The key difference: Seagate Technology Holdings PLC is far larger — about 78.1× GeneDx Holdings Corp's market cap, and Seagate Technology Holdings PLC pays a 0.33% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| STX | WGS | |
|---|---|---|
Market Cap | $201.45B | $2.58B |
Sector | Technology | Technology |
52-Week High | $1.09K | $167.51 |
52-Week Low | $193.04 | $34.51 |
Enterprise Value | $203.61B | $2.61B |
Dividend Yield | 0.33% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
STX trades at $904.38, up 6.49% in 24 hours, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust profitability with a net income margin of 26.11% and high ROE of 371.53%, though valuation ratios like P/E of 65.06 appear elevated. Recent news highlights AI-driven storage demand and HAMR technology advancements fueling growth, with revenue projected to rise to $12.2B in 2026.
Outlook is positive due to AI infrastructure demand and earnings momentum, but risks include high debt levels and valuation concerns. Analysts are bullish with a consensus price target of $1,130, suggesting upside potential, though investors should monitor execution risks and market volatility.
WGS trades at $85.87, down 0.14% on the day, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4 million, beating estimates, and achieved adjusted profitability ahead of schedule. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics, driving positive sentiment.
Outlook is cautiously optimistic due to strong analyst support (90.9% buy ratings) and revenue growth, but risks include negative net income margins, high valuation multiples, and ongoing class action lawsuits. The stock's upside potential hinges on sustained operational improvements and market expansion in genomics diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
